# Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions

> **NCT04577469** · PHASE1 · UNKNOWN · sponsor: **Emzor Pharmaceutical Industries Limited** · enrollment: 52 (estimated)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Maldox tablets
- **DRUG:** G-COSPE® tablets

## Key facts

- **NCT ID:** NCT04577469
- **Lead sponsor:** Emzor Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04577469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04577469, "Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04577469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*